BTI’s Schumacher steps down from post

Article

The chief executive of San Diego-based magnetic source imaging developer Biomagnetic Technologies stepped down last month. James Schumacher, a GE Medical Systems veteran who led BTI since 1993, will be replaced as president and CEO by Scott Buchanan.

The chief executive of San Diego-based magnetic source imaging developer Biomagnetic Technologies stepped down last month. James Schumacher, a GE Medical Systems veteran who led BTI since 1993, will be replaced as president and CEO by Scott Buchanan. Schumacher remains on BTI's board, while the company's office of chairman will remain vacant.

The move was part of BTI's effort to cut costs by reducing management overhead, Schumacher said. BTI implemented a restructuring earlier this year after a delay in shipments of its Magnes 2500 Whole Head system resulted in a revenue shortfall (SCAN 2/5/97).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.